Trastuzumab, CAS [[180288-69-1]]

Produktübersicht

• Artikelname: Trastuzumab, CAS [[180288-69-1]]
• Artikelnummer: TGM-T9912
• Hersteller Artikelnummer: T9912
• Alternativnummer: TGM-T9912-1MG,TGM-T9912-5MG,TGM-T9912-10MG,TGM-T9912-25MG,TGM-T9912-50MG,TGM-T9912-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.

Produkteigenschaften

• Molekulargewicht: Approximately 145.53 kDa
• Reinheit: 99.50%
• CAS Nummer: [180288-69-1]
• Target-Kategorie: ADC Antibody|||EGFR

Bilder

T9912